Ingenol 3-angelate

Ingenol 3-angelate is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 455 references associated with Ingenol 3-angelate in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

All references with Ingenol 3-angelate

Download all related citations
Per page 10 20 50 100 | Total 138
Authors Title Published Journal PubMed Link
Jiang G et al. Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation. 2015 PLoS Pathog. pmid:26225771
Freiberger SN et al. Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2. 2015 Mol. Cancer Ther. pmid:26116359
Soini EJ et al. Cost-utility of first-line actinic keratosis treatments in Finland. 2015 Adv Ther pmid:26006101
Cantisani C et al. Evaluation of Ingenol mebutate efficacy for the treatment of actinic keratosis with Antera 3D camera. 2015 Eur Rev Med Pharmacol Sci pmid:25635981
Edwards SK et al. N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma. 2013 BMC Cancer pmid:24131623
Song X et al. RasGRPs are targets of the anti-cancer agent ingenol-3-angelate. 2013 PLoS ONE pmid:23991094
Cozzi SJ et al. Effective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 mice. 2013 Arch. Dermatol. Res. pmid:22871992
Liang X et al. Syntheses, biological evaluation and SAR of ingenol mebutate analogues for treatment of actinic keratosis and non-melanoma skin cancer. 2013 Bioorg. Med. Chem. Lett. pmid:23993332
Doan HQ et al. Ingenol mebutate: potential for further development of cancer immunotherapy. 2012 J Drugs Dermatol pmid:23134979
Lebwohl M et al. Ingenol mebutate gel for actinic keratosis. 2012 N. Engl. J. Med. pmid:22417254

Table of Content